Restless legs syndrome (RLS) is a sleep and movement disorder that affects up to 15% of the population across the lifespan. Many health care providers have doubted its validity as an illness and are uncertain as to the implications of health care outcomes. The cause of RLS is unknown. Common treatment options include dopaminergics, benzodiazepines, and opioids; however, the pharmacogenetic mechanisms of treatment are unknown. One of the greatest genetic discoveries in 2007 was the identification of genetic variance associated with RLS. There is, however, a lack of knowledge related to RLS and its genetic basis. Therefore, the purposes of this article are to (a) provide information about the science of clinical care related to RLS; (b) present a systematic review of the literature on the status of genetics/genomics of RLS, including the discovery of associated genetic variance; and (c) identify implications of the current state of the science for health care providers and biobehavioral researchers. With the continuing genetic discoveries in RLS, health care providers, specifically nurses who play a major role in research, genetic counseling, and education, need to understand the implications of this sleep and movement disorder for patients across the lifespan.
Allen, R.P., Barker, P.B., Wehrl, F., Song, H.K., & Earley, C.J. ( 2001). MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 56, 263-265.
3.
Allen, R.P., & Earley, C.J. ( 1996). Augmentation of the restless legs syndrome with carbidopa/levodopa . Sleep, 19, 205-213.
4.
Allen, R.P., & Earley, C.J. ( 2000). Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Medicine, 1, 11-19.
5.
Allen, R.P., & Earley, C.J. ( 2001). Restless legs syndrome: A review of clinical and pathophysiologic features. Journal of Clinical Neurophysiology, 18, 128-147.
6.
Antonini, A., & Poewe, W. ( 2007). Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease. Lancet Neurology, 6, 826-829.
7.
Baker, W.L., White, C.M., & Coleman, C.I. ( 2008). Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Annals of Family Medicine, 6, 253-262.
8.
Bassetti, C.L., Mauerhofer, D., Gugger, M., Mathis, J., & Hess, C.W. ( 2001). Restless legs syndrome: A clinical study of 55 patients . European Neurology, 45, 67-74.
9.
Bastuji, H., & Garcia-Larrea, L. (1999). Sleep/wake abnormalities in patients with periodic leg movements during sleep: Factor analysis on data from 24-h ambulatory polygraphy. Journal of Sleep Research , 8, 217-223.
10.
Bianco, L.E., Wiesinger, J., Earley, C.J., Jones, B.C., & Beard, J.L. ( 2008). Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats. Journal of Neuro-chemistry , 106, 205-215.
11.
Bonati, M.T., Ferini-Strambi, L., Aridon, P., Oldani, A., Zucconi, M., & Casari, G. ( 2003). Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain, 126, 1485-1492.
12.
Chen, S., Ondo, W.G., Rao, S., Li, L., Chen, Q., & Wang, Q. ( 2004). Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. American Journal of Human Genetics, 74, 876-885.
13.
Chesson, A.L., Jr., Wise, M., Davila, D., Johnson, S., Littner, M., Anderson, W.M., et al. (1999). Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep, 22, 961-968.
14.
Coccagna, G., Vetrugno, R., Lombardi, C., & Provini, F. ( 2004). Restless legs syndrome: An historical note. Sleep Medicine, 5, 279-283.
15.
Connor, J.R., Boyer, P.J., Menzies, S.L., Dellinger, B., Allen, R.P., Ondo, W.G., et al. (2003). Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology, 61, 304-309.
16.
Connor, J.R., Wang, X.S., Patton, S.M., Menzies, S.L., Troncoso, J.C., Earley, C.J., et al. (2004). Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology , 62, 1563-1567.
17.
Cuellar, N.G. ( 2004). Diagnosis and treatment of persons with restless legs syndrome. Clinical Excellence for Nurse Practitioners, 8, 5-13.
18.
Cuellar, N.G., & Ratcliffe, S.J. (2008). A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome. Journal of Clinical Sleep Medicine , 4, 50-56.
19.
Cuellar, N.G., Ratcliffe, S.J., & Chien, D. ( 2006). Effects of depression on sleep quality, fatigue, and sleepiness in persons with restless legs syndrome. Journal of the American Psychiatric Nurses Association, 12, 262-271.
20.
Cuellar, N.G., Strumpf, N.E., & Ratcliffe, S.J. (2007). Symptoms of restless legs syndrome in older adults: Outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. Journal of the American Geriatrics Society, 55, 1387-1392.
21.
Curtice, T.G., Long, S.R., Baser, O., Montejano, L.B., & Lobo, F. ( 2006). Economic burden of restless legs syndrome in a privately-insured population. Value in Health, A9, 85.
22.
Danoff, S.K., Grasso, M.E., Terry, P.B., & Flynn, J.A. ( 2001). Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest, 120, 313-316.
23.
Desai, A.V., Cherkas, L.F., Spector, T.D., & Williams, A.J. (2004). Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: A twin study. Twin Research, 7, 589-595.
24.
Desautels, A., Turecki, G., Montplaisir, J., Brisebois, K., Sequeira, A., Adam, B., et al. (2002). Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology , 59, 215-219.
25.
Desautels, A., Turecki, G., Montplaisir, J., Ftouhi-Paquin, N., Michaud, M., Chouinard, V.A., et al. (2001). Dopaminergic neurotransmission and restless legs syndrome: A genetic association analysis. Neurology, 57, 1304-1306.
26.
Desautels, A., Turecki, G., Montplaisir, J., Sequeira, A., Verner, A., & Rouleau, G.A. ( 2001). Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. American Journal of Human Genetics, 69, 1266-1270.
27.
Desautels, A., Turecki, G., Montplaisir, J., Xiong, L., Walters, A.S., Ehrenberg, B.L., et al. (2005). Restless legs syndrome: Confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity . Archives of Neurology, 62, 591-596.
28.
Desautels, A., Turecki, G., Xiong, L., Rochefort, D., Montplaisir, J., & Rouleau, G.A. ( 2004). Mutational analysis of neurotensin in familial restless legs syndrome. Movement Disorders, 19, 90-94.
29.
Dewey, R.B. 2nd, Reimold, S.C., & O’Suilleabhain, P.E. (2007). Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson’s disease . Archives of Neurology, 64, 377-380.
30.
Douzinas, N., Connolly, M.P., Kirsch, J., & Morris, S. ( 2005). Establishing the indirect costs of RLS based on severity using the International restless legs severity rating scale (IRLS) and the productivity and activity impairment. European Journal of Neurology, 12, 105.
31.
Earley, C.J., Allen, R.P., Beard, J.L., & Connor, J.R. ( 2000). Insight into the pathophysiology of restless legs syndrome . Journal of Neuroscience Research, 62, 623-628.
32.
Earley, C.J., Connor, J.R., Beard, J.L., Clardy, S.L., & Allen, R.P. ( 2005). Ferritin levels in the cerebrospinal fluid and restless legs syndrome: Effects of different clinical phenotypes. Sleep, 28, 1069-1075.
33.
Ekbom, K.A. ( 1960). Restless legs syndrome. Neurology, 10, 873.
34.
Esteves, A.M., Pedrazzoli, M., Bagnato, M., Moreira, F., Mello, M.T.D., & Tufik, S. ( 2008). Two pedigrees with restless legs syndrome in Brazil. Brazilian Journal of Medical & Biological Research, 41, 106-109.
35.
Ferini-Strambi, L., Bonati, M.T., Oldani, A., Aridon, P., Zucconi, M., & Casari, G. ( 2004). Genetics in restless legs syndrome. Sleep Medicine, 5, 301-304.
36.
Fulda, S., & Wetter, T.C. ( 2008). Where dopamine meets opioids: A meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain, 131, 902-917.
37.
Gamaldo, C.E., & Earley, C.J. ( 2006). Restless legs syndrome: A clinical update. Chest, 130, 1596-1604.
38.
Garcia-Borreguero, D., Allen, R.P., Kohnen, R., Hogl, B., Trenkwalder, C., Oertel, W., et al. (2007). Diagnostic standards for dopaminergic augmentation of restless legs syndrome: Report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Medicine, 8, 520-530.
39.
Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Granizo, J.J., & Allen, R. ( 2004). Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Medicine, 5, 561-565.
40.
Hanson, M., Honour, M., Singleton, A., Crawley, A., Hardy, J., & Gwinn-Hardy, K. (2004). Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features . Journal of Neurology, 251, 1398-1401.
41.
Hening, W.A., Allen, R.P., Earley, C.J., Picchietti, D.L., & Silber, M.H., & Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. ( 2004). An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 27, 560-583.
42.
Hening, W.A., Walters, A.S., Allen, R.P., Montplaisir, J., Myers, A., & Ferini-Strambi, L. (2004). Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Medicine, 5, 237-246.
43.
Heschl, A. ( 1992). Behaviour and the concept of ‘‘heritability’’ axioms of an ethological refutation. Acta Biotheoretica, 40, 23-30.
44.
Hogl, B., Kiechl, S., Willeit, J., Saletu, M., Frauscher, B., Seppi, K., et al. (2005). Restless legs syndrome: A community-based study of prevalence, severity, and risk factors. Neurology , 64, 1920-1924.
45.
Hornyak, M., & Trenkwalder, C. (2004). Restless legs syndrome and periodic limb movement disorder in the elderly. Journal of Psychosomatic Research, 56, 543-548.
46.
Human Genome Project Information. (2007, May 11). Retrieved December 10, 2009, from http://www.ornl.gov/sci/techresources/Human_Genome/glossary/index.shtml
47.
Karatas, M. ( 2007). Restless legs syndrome and periodic limb movements during sleep: Diagnosis and treatment. Neurologist, 13, 294-301.
48.
Kemlink, D., Plazzi, G., Vetrugno, R., Provini, F., Polo, O., Stiasny-Kolster, K., et al. (2008). Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics, 9, 75-82.
49.
Kemlink, D., Polo, O., Montagna, P., Provini, F., Stiasny-Kolster, K., Oertel, W., et al. (2007). Family-based association study of the restless legs syndrome loci 2 and 3 in aEuropean population. Movement Disorders, 22, 207-212.
50.
Lavigne, G.J., & Montplaisir, J.Y. (1994). Restless legs syndrome and sleep bruxism: Prevalence and association among Canadians. Sleep, 17, 739-743.
51.
Lazzarini, A., Walters, A.S., Hickey, K., Coccagna, G., Lugaresi, E., Ehrenberg, B.L., et al. (1999). Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Movement Disorder, 14, 111-116.
52.
Levchenko, A., Montplaisir, J.Y., Dube, M.P., Riviere, J.B., St-Onge, J., Turecki, G., et al. (2004). The 14q restless legs syndrome locus in the FrenchCanadian population. Annals of Neurology, 55, 887-891.
53.
Levchenko, A., Provost, S., Montplaisir, J., Xiong, L., St-Onge, J., Thibodeau, P., et al. (2006). A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology, 67, 900-901.
54.
Liebetanz, K.M., Winkelmann, J., Trenkwalder, C., Putz, B., Dichgans, M., Gasser, T., et al. (2006). RLS3: Fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity. Neurology , 67, 320-321.
55.
Lohmann-Hedrich, K., Neumann, A., Kleensang, A., Lohnau, T., Muhle, H., Djarmati, A., et al. (2008). Evidence for linkage of restless legs syndrome to chromosome 9p: Are there two distinct loci? Neurology, 70, 686-694.
56.
Mathias, R.A., Hening, W., Washburn, M., Allen, R.P., Lesage, S., Wilson, A.F., et al. (2006). Segregation analysis of restless legs syndrome: Possible evidence for a major gene in a family study using blinded diagnoses . Human Heredity, 62, 157-164.
57.
Maurel, F., Girard, B., Crochard, A., Henri, M., El Hasnaoui, A., & Le Pen, C. (2004). Profile of patients suffering from restless legs syndrome and estimation of their annual cost in an ambulatory care setting in France. Value in Health, 7, 658-805.
58.
McCormack, P.L., & Siddiqui, M.A.A. (2007). Pramipexole: In restless legs syndrome. CNS Drugs, 21, 429-440.
59.
Mignot, E. ( 2007). A step forward for restless legs syndrome. Nature Genetics, 39, 938-939.
60.
Milligan, S.A., & Chesson, A.L. ( 2002). Restless legs syndrome in the older adult: Diagnosis and management. Drugs & Aging, 19, 741-751.
61.
Molokwu, O.C. ( 2008). Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting. Annals of Pharmacotherapy, 42, 627-632.
62.
Montplaisir, J., Boucher, S., Poirier, G., Lavigne, G., Lapierre, O., & Lesperance, P. (1997). Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria. Movement Disorders, 12, 61-65.
63.
Montplaisir, J., Godbout, R., Boghen, D., DeChamplain, J., Young, S.N., & Lapierre, G. ( 1985). Familial restless legs with periodic movements in sleep: Electrophysiologic, biochemical, and pharmacologic study. Neurology, 35, 130-134.
64.
Mulero-Navarro, S., & Esteller, M. ( 2008). Epigenetic biomarkers for human cancer: The time is now . Critical Reviews in Oncology-Hematology, 68, 1-11.
65.
National Human Genome Research Institute. (2008, June 12). Retrieved December 7, 2009, from http://www.genome.gov/20019523
66.
Obah, C., & Fine, P.G. ( 2006). Restless legs syndrome: An update on diagnosis and management . Journal of Pain & Palliative Care Pharmacotherapy, 20, 85-88.
67.
Ohayon, M.M., & Roth, T. ( 2002). Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. Journal of Psychosomatic Research, 53, 547-554.
68.
Ondo, W.G., He, Y., Rajasekaran, S., & Le, W.D. ( 2000). Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome . Movement Disorders, 15, 154-158.
69.
Ondo, W.G., Vuong, K.D., & Wang, Q. ( 2000). Restless legs syndrome in monozygotic twins: Clinical correlates. Neurology, 55, 1404-1406.
70.
Oppenheim, H. ( 1923). Lehrbuch der Nervenkrankheiten (7th ed.). Berlin: Karger.
71.
Parker, K.P., & Rye, D.B. ( 2002). Restless legs syndrome and periodic limb movement disorder . Nursing Clinics of North America, 37, 655-673.
72.
Phillips, B., Young, T., Finn, L., Asher, K., Hening, W.A., & Purvis, C. ( 2000). Epidemiology of restless legs symptoms in adults. Archives of Internal Medicine, 160, 2137-2141.
73.
Pichler, I., Marroni, F., Volpato, C.B., Gusella, J.F., Klein, C., Casari, G., et al. (2006). Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. American Journal Human Genetics, 79, 716-723.
74.
Rothdach, A.J., Trenkwalder, C., Haberstock, J., Keil, U., & Berger, K. ( 2000). Prevalence and risk factors of RLS in an elderly population: The MEMO study. Neurology, 54, 1064-1068.
75.
Schapira, A.H. ( 2004). Restless legs syndrome: An update on treatment options . Drugs, 64, 149-158.
76.
Schormair, B., Kemlink, D., Roeske, D., Eckstein, G., Xiong, L., Lichtner, P., et al. (2008). PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics, 40, 946-948.
77.
Sforza, E., Nicolas, A., Lavigne, G., Gosselin, A., Petit, D., & Montplaisir, J. (1999). EEG and cardiac activation during periodic leg movements in sleep: Support for a hierarchy of arousal responses. Neurology, 52, 786-791.
78.
Silver, L. ( 2007, October 15). The year of miracles. Newsweek . Retrieved December 10, 2009, from http://www.newsweek.com/id/42525
79.
Stefansson, H., Rye, D.B., Hicks, A., Petursson, H., Ingason, A., Thorgeirsson, T.E., et al. (2007). A genetic risk factor for periodic limb movements in sleep. New England Journal of Medicine, 357, 639-647.
80.
Stiasny, K., Robbecke, J., Schuler, P., & Oertel, W.H. ( 2000). Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline-an open clinical trial. Sleep , 23, 349-354.
Tan, E.K., & Ondo, W. ( 2000). Restless legs syndrome: Clinical features and treatment . American Journal of the Medical Sciences, 319, 397-403.
83.
Trenkwalder, C. ( 2006). The weight of evidence for ropinirole in restless legs syndrome. European Journal of Neurology, 13 Suppl 3, 21-30.
84.
Trenkwalder, C., Seidel, V.C., Gasser, T., & Oertel, W.H. ( 1996). Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Movement Disorders , 11, 389-394.
85.
Tuisku, K., Holi, M.M., Wahlbeck, K., Ahlgren, A.J., & Lauerma, H. ( 2005). Actometry in measuring the symptom severity of restless legs syndrome. European Journal of Neurology, 12, 385-387.
86.
Ulfberg, J., Nystrom, B., Carter, N., & Edling, C. ( 2001). Prevalence of restless legs syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms . Movement Disorders, 16, 1159-1163.
87.
Walters, A.S., Hickey, K., Maltzman, J., Verrico, T., Joseph, D., Hening, W., et al. (1996). A questionnaire study of 138 patients with restless legs syndrome: The ‘‘night-walker’s’’ survey. Neurology, 46, 92-95.
88.
Wang, X., Wiesinger, J., Beard, J., Felt, B., Menzies, S., Earley, C., et al. (2004). Thy1 expression in the brain is affected by iron and is decreased in restless legs syndrome. Journal of the Neurological Sciences, 220, 59-66.
89.
Weimerskirch, P.R., & Ernst, M.E. ( 2001). Newer dopamine agonists in the treatment of restless legs syndrome. Annals of Pharmacotherapy, 35, 627-630.
90.
Werra, R.J. ( 2001). Restless legs syndrome: A common, underdiagnosed condition . Family Practice Recertification, 23, 43-46, 49-50, 52 passim.
91.
Willis, T. ( 1685). The London practice of physick. London : Bassett and Crooke.
92.
Winkelmann, J.W. ( 2007). Periodic limb movements in sleep- endophenotype for restless legs syndrome? New England Journal of Medicine, 357, 703-705.
93.
Winkelmann, J.W. ( 2008). Genetics of restless legs syndrome. Current Neurology & Neuroscience Reports, 8, 211-216.
94.
Winkelmann, J.W., Finn, L., & Young, T. ( 2006). Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Medicine, 7, 545-552.
95.
Winkelmann, J.W.Lichtner, P., Putz, B., Trenkwalder, C., Hauk, S., Meitinger, T., et al. (2006). Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome. Movement Disorders, 21, 28-33.
96.
Winkelmann, J.W., Lichtner, P., Schormair, B., Uhr, M., Hauk, S., Stiasny-Kolster, K., et al. (2008). Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Movement Disorders, 23, 350-358.
97.
Winkelmann, J.W., & Muller-Myhsok, B. (2008). Genetics of restless legs syndrome: A burning urge to move. Neurology, 70, 664-665.
98.
Winkelmann, J.W., Muller-Myhsok, B., Wittchen, H.U., Hock, B., Prager, M., Pfister, H., et al. (2002). Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Annals of Neurology, 52, 297-302.
99.
Winkelmann, J.W., Polo, O., Provini, F., Nevsimalova, S., Kemlink, D., Sonka, K., et al. (2007). Genetics of restless legs syndrome (RLS): State-of-the-art and future directions. Movement Disorders , 22, S449-S558.
100.
Winkelmann, J.W., Schormair, B., Lichtner, P., Ripke, S., Xiong, L., Jalilzadeh, S., et al. (2007). Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nature Genetics, 39, 1000-1006.
101.
Winkelmann, J.W., Wetter, T.C., Collado-Seidel, V., Gasser, T., Dichgans, M., Yassouridis, A., et al. (2000). Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep, 23, 597-602.
102.
Wittmaack, T. ( 1861). Pathologie und therapie der sensibilitat neurosen. Leipzig: Schafer.
103.
Xiong, L., Dion, P., Montplaisir, J., Levchenko, A., Thibodeau, P., Karemera, L., et al. (2007). Molecular genetic studies of DMT1 on 12q in French-Canadian restless legs syndrome patients and families. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics, 144, 911-917.
104.
Xiong, L., Jang, K., Montplaisir, J., Levchenko, A., Thibodeau, P., Gaspar, C., et al. (2007). Canadian restless legs syndrome twin study . Neurology, 68, 1631-1633.
105.
Xiong, L., Levchenko, A., Montplaisir, J., Riviere, J.-B., Thibodeau, P., St-Onge, J., et al. (2008). Genetic association studies of neurotensin gene and restless legs syndrome in French Canadians. Sleep Medicine, 9, 273-282.
